查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1842236

全球靜脈輸液治療市場：市場規模、佔有率、趨勢分析（按服務、組件、提供者類型和地區分類）、細分市場預測（2025-2033 年）

Intravenous Hydration Therapy Market Size, Share & Trends Analysis Report By Service (Immune Boosters, Energy Boosters), By Component (Medicated, Non-medicated), By Provider Type, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 190 Pages | 商品交期: 2-10個工作天內

價格

靜脈輸液療法：市場概覽

全球靜脈輸液治療市場預計在 2024 年達到 26.4 億美元，預計到 2033 年將達到 56.6 億美元，2025 年至 2033 年的複合年成長率為 9.0%。

這一成長歸因於慢性病患病率的上升、健康和美容療法的日益普及、靜脈輸液（IV）補液療法診所的日益增多以及該療法的易用性。

靜脈輸液療法的需求日益成長，其驅動力源自於人們對便利性、個人化健康方案的追求，而不僅限於傳統的臨床照護。例如，2025年8月，AquaPulse IV在維吉尼亞弗雷德里克斯堡推出了行動靜脈輸液服務，由執照醫療專業人員直接為客戶家中、職場和活動地點提供個人化的輸液和維生素補充。這項發展表明，靜脈輸液療法正逐漸融入人們的生活方式和預防保健實踐，在符合人們日常生活的環境中提供快速恢復、能量補充和免疫支持。這種按需服務模式凸顯了健康服務領域對便利性和以病人為中心的照護日益成長的重視。

消費者對預防性健康、復健方案和個人化照護模式日益成長的興趣，正在推動靜脈輸液療法市場的擴張。除了傳統的補液和營養支持外，醫療機構還提供專業服務，以支持長期健康目標。例如，Hydration Room 於 2025 年 5 月推出了 NAD+ 靜脈輸液會員服務，提供分級劑量方案，旨在增強大腦健康、提升精力和延長壽命。該服務提供每月靈活劑量的臨床管理 NAD+ 療法，體現了訂閱式客製化護理的更廣泛趨勢，這種護理模式優先考慮一致性、便利性和主動健康管理。這些創新，以及行動輸液服務和技術賦能的交付模式的發展，正在將靜脈輸液療法轉變為一種主流的健康選擇，適用於急性復健和持續的健康最佳化。

此外，靜脈輸液療法因其護膚功效而在美容行業廣受歡迎。大量研究表明，該治療方法透過為肌膚補水來輔助美容治療，進一步改善個人外觀。靜脈輸液療法被認為能夠促進彈性蛋白和膠原蛋白的正常生成，從而維持肌膚的年輕健康狀態。隨著時間的推移，這有助於減少皺紋和細紋的出現。

目錄

第1章 分析方法和範圍

第2章執行摘要

第3章 市場因素、趨勢與範圍

  • 市場聯動展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 產業機會分析
    • 產業挑戰分析
  • 商業環境分析
    • 波特五力分析
    • PESTEL 分析

第4章 靜脈輸液（IV）補液療法市場：按服務類型分類的估算和趨勢分析

  • 服務專用儀表板
  • 按服務類型分類的市佔率及波動分析（2024 年及 2033 年）
  • 按服務分類的市場規模預測和趨勢分析（2021-2033）
  • 免疫增強劑
  • 能量增強劑
  • 水合作用
  • 美/美學
  • 排毒
  • 長壽/抗老
  • 競技/運動
  • 偏頭痛和疼痛緩解
  • 壓力/睡眠/情緒支持
  • 流感/腸胃炎
  • 其他

5. 靜脈輸液（IV）補液療法市場：按成分分類的估算和趨勢分析

  • 組件專屬儀錶板
  • 按組件分類的市場佔有率和波動分析（2024 年和 2033 年）
  • 按組件分類的市場規模預測和趨勢分析（2021-2033）
  • 藥用
  • 非藥用

6. 靜脈輸液（IV）補液療法市場：按服務提供者類型分類的估算和趨勢分析

  • 提供者類型儀表板
  • 按供應商類型分類的市佔率及變化分析（2024 年及 2033 年）
  • 按供應商類型分類的市場規模預測和趨勢分析（2021-2033 年）
  • 行動電信商
  • 實體提供者

7. 靜脈輸液（IV）補液療法市場：依最終用途分類的估算與趨勢分析

  • 終端用戶儀錶板
  • 依最終用途分類的市佔率及變化分析（2024 年及 2033 年）
  • 按最終用途分類的市場規模預測和趨勢分析（2021-2033 年）
  • 醫療保健提供者
  • 醫院和診所
  • 健康中心/水療中心
  • 居家醫療
  • 其他

8. 靜脈輸液療法市場：區域估算與趨勢分析

  • 市場概覽：按地區
  • 區域市場：主要結論
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭情勢

  • 參與企業概況
  • 企業市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介/上市公司
    • Baxter International Inc.
    • B. Braun Melsungen AG
    • Otsuka Pharmaceutical Co., Ltd.
    • Grifols, SA
    • Vifor Pharma Management Ltd.
    • JW Life Science Corporation
    • Amanta Healthcare
    • NexGen Health
    • Core IV Therapy, LLC
    • Cryojuvenate UK Ltd.
    • REVIV
Product Code: GVR-4-68040-076-0

Intravenous Hydration Therapy Market Summary

The global intravenous hydration therapy market size was estimated at USD 2.64 billion in 2024 and is projected to reach USD 5.66 billion by 2033, growing at a CAGR of 9.0% from 2025 to 2033. This growth is attributed to the rising prevalence of chronic diseases, the growing popularity of wellness and beauty treatments, and the increasing availability of intravenous (IV) hydration therapy clinics, as well as the ease of use associated with this therapy.

The increasing demand for IV hydration therapy is driven by the shift toward convenient, personalized wellness options beyond traditional clinical care. For instance, in August 2025, AquaPulse IV introduced mobile IV therapy services in Fredericksburg, Virginia. The service provides customized hydration and vitamin infusions directly to clients' homes, workplaces, or events, administered by licensed medical professionals. This development shows how IV therapy is becoming part of a lifestyle and preventive health approach, offering people quick recovery, energy boosts, and immune support in environments that fit their daily routines. These on-demand models highlight the rising focus on accessibility and patient-centered care in wellness services.

Growing consumer interest in preventive wellness, recovery solutions, and personalized care models is driving the expansion of the IV hydration therapy market. Beyond traditional hydration and nutrient replacement, providers offer specialized services supporting long-term health goals. For instance, in May 2025, Hydration Room introduced the NAD+ IV Membership with tiered dosing options to enhance brain health, energy, and longevity. By providing monthly access to clinically supervised NAD+ therapy in flexible doses, the program exemplifies a wider trend toward subscription-based, customized care that prioritizes consistency, convenience, and proactive health management. These innovations, along with the growth of mobile IV services and tech-enabled delivery models, are turning IV hydration therapy into a mainstream wellness option that serves both acute recovery and ongoing health optimization.

Furthermore, IV hydration therapy has gained immense popularity in the cosmetic industry, owing to the skincare benefits offered by the procedure. Extensive research found that the therapy helps in providing beauty treatment by hydrating the skin, further enhancing the appearance of an individual. IV hydration therapy is believed to enhance the normal production of elastin and collagen, which are responsible for maintaining youthful and healthy-looking skin. This can help to reduce the appearance of wrinkles and fine lines over time.

Global Intravenous (IV) Hydration Therapy Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global intravenous (IV) hydration therapymarket report based on service, component, provider type, end use and regions.

  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Immune Boosters
  • Energy Boosters
  • Hydration
  • Beauty/ Aesthetics
  • Detoxification
  • Longevity/ Antiaging
  • Performance/ Athletics
  • Migraine & Pain Relief
  • Stress/Sleep/Mood Support
  • Flu/Stomach
  • Others
  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Medicated
  • Non-medicated
  • Provider Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Mobile Providers
  • Physical Providers
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Wellness Centers and Spas
  • Home Healthcare
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Component
    • 1.2.3. Provider Type
    • 1.2.4. End use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing demand for quick rehydration and recovery solutions
      • 3.2.1.2. Increasing adoption of wellness and preventive healthcare trends
      • 3.2.1.3. Rising popularity of IV nutrient therapy for beauty, skin rejuvenation, and anti-aging benefits
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Risk of side effects, including infections, vein inflammation, or allergic reactions
      • 3.2.2.2. High cost of treatments compared to oral supplements and conventional care
      • 3.2.2.3. Limited insurance coverage, making therapies less accessible to many patients
    • 3.2.3. Industry Opportunity Analysis
    • 3.2.4. Industry Challenge Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal Landscape

Chapter 4. Intravenous (IV) Hydration Therapy Market: Service Estimates & Trend Analysis

  • 4.1. Service Segment Dashboard
  • 4.2. Service Market Share Movement Analysis, 2024 & 2033
  • 4.3. Market Size & Forecasts and Trend Analysis, by Service, 2021 to 2033 (USD Million)
  • 4.4. Immune Boosters
    • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Energy Boosters
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Hydration
    • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Beauty/ Aesthetics
    • 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Detoxification
    • 4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. Longevity/ Antiaging
    • 4.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.10. Performance/ Athletics
    • 4.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.11. Migraine & Pain Relief
    • 4.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.12. Stress/Sleep/Mood Support
    • 4.12.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.13. Flu/Stomach
    • 4.13.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.14. Others
    • 4.14.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Intravenous (IV) Hydration Therapy Market: Component Estimates & Trend Analysis

  • 5.1. Component Segment Dashboard
  • 5.2. Component Market Share Movement Analysis, 2024 & 2033
  • 5.3. Market Size & Forecasts and Trend Analysis, by Component, 2021 to 2033 (USD Million)
  • 5.4. Medicated
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Non-Medicated
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Intravenous (IV) Hydration Therapy Market: Provider Type Estimates & Trend Analysis

  • 6.1. Provider Type Dashboard
  • 6.2. Provider Type Market Share Movement Analysis, 2024 & 2033
  • 6.3. Market Size & Forecasts and Trend Analysis, by Provider Type, 2021 to 2033 (USD Million)
  • 6.4. Mobile Providers
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Physical Providers
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Intravenous (IV) Hydration Therapy Market: End Use Estimates & Trend Analysis

  • 7.1. End use Segment Dashboard
  • 7.2. End use Market Share Movement Analysis, 2024 & 2033
  • 7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Healthcare Providers
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Hospitals & Clinics
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Wellness Centers & Spas
    • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Home Healthcare
    • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Others
    • 7.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Intravenous (IV) Hydration Therapy Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Dashboard
  • 8.2. Regional Market: Key Takeaways
  • 8.3. North America
    • 8.3.1. North America Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key country dynamic
      • 8.3.2.2. Regulatory framework
      • 8.3.2.3. Competitive insights
      • 8.3.2.4. U.S. Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key country dynamic
      • 8.3.3.2. Regulatory framework
      • 8.3.3.3. Competitive insights
      • 8.3.3.4. Canada Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key country dynamic
      • 8.3.4.2. Regulatory framework
      • 8.3.4.3. Competitive insights
      • 8.3.4.4. Mexico Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamic
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Competitive insights
      • 8.4.2.4. Germany Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. UK
      • 8.4.3.1. Key country dynamic
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Competitive insights
      • 8.4.3.4. UK Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key country dynamic
      • 8.4.4.2. Regulatory framework
      • 8.4.4.3. Competitive insights
      • 8.4.4.4. France Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key country dynamic
      • 8.4.5.2. Regulatory framework
      • 8.4.5.3. Competitive insights
      • 8.4.5.4. Italy Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key country dynamic
      • 8.4.6.2. Regulatory framework
      • 8.4.6.3. Competitive insights
      • 8.4.6.4. Spain Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key country dynamic
      • 8.4.7.2. Regulatory framework
      • 8.4.7.3. Competitive insights
      • 8.4.7.4. Denmark Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key country dynamic
      • 8.4.8.2. Regulatory framework
      • 8.4.8.3. Competitive insights
      • 8.4.8.4. Sweden Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key country dynamic
      • 8.4.9.2. Regulatory framework
      • 8.4.9.3. Competitive insights
      • 8.4.9.4. Norway Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key country dynamic
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive insights
      • 8.5.2.4. Japan Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key country dynamic
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive insights
      • 8.5.3.4. China Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key country dynamic
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Competitive insights
      • 8.5.4.4. India Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamic
      • 8.5.5.2. Regulatory framework
      • 8.5.5.3. Competitive insights
      • 8.5.5.4. South Korea Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key country dynamic
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Competitive insights
      • 8.5.6.4. Australia Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key country dynamic
      • 8.5.7.2. Regulatory framework
      • 8.5.7.3. Competitive insights
      • 8.5.7.4. Thailand Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Intravenous (IV) Hydration Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key country dynamic
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive insights
      • 8.6.2.4. Brazil Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key country dynamic
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive insights
      • 8.6.3.4. Argentina Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key country dynamic
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive insights
      • 8.7.2.4. South Africa Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key country dynamic
      • 8.7.3.2. Regulatory framework
      • 8.7.3.3. Competitive insights
      • 8.7.3.4. Saudi Arabia Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key country dynamic
      • 8.7.4.2. Regulatory framework
      • 8.7.4.3. Competitive insights
      • 8.7.4.4. UAE Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key country dynamic
      • 8.7.5.2. Regulatory framework
      • 8.7.5.3. Competitive insights
      • 8.7.5.4. Kuwait Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. Baxter International Inc.
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial performance
      • 9.5.1.3. Product benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. B. Braun Melsungen AG
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial performance
      • 9.5.2.3. Product benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Otsuka Pharmaceutical Co., Ltd.
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial performance
      • 9.5.3.3. Product benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. Grifols, S.A.
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial performance
      • 9.5.4.3. Product benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. Vifor Pharma Management Ltd.
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial performance
      • 9.5.5.3. Product benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. JW Life Science Corporation
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial performance
      • 9.5.6.3. Product benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. Amanta Healthcare
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. NexGen Health
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. Core IV Therapy, LLC
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. Cryojuvenate UK Ltd.
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product benchmarking
      • 9.5.10.4. Strategic initiatives
    • 9.5.11. REVIV
      • 9.5.11.1. Overview
      • 9.5.11.2. Financial performance
      • 9.5.11.3. Product benchmarking
      • 9.5.11.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 List of secondary data sources
  • Table 3 North America Intravenous (IV) Hydration Therapy market, by country, 2021 - 2033 (USD Million)
  • Table 4 North America Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 5 North America Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 6 North America Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 7 North America Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 8 U.S. Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 9 U.S. Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 10 U.S. Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 11 U.S. Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 12 Canada Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 13 Canada Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 14 Canada Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 15 Canada Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 17 Mexico Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 18 Mexico Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 19 Mexico Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Europe Intravenous (IV) Hydration Therapy market, by country, 2021 - 2033 (USD Million)
  • Table 21 Europe Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 22 Europe Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 23 Europe Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 24 Europe Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 25 Germany Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 26 Germany Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 27 Germany Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 28 Germany Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 29 Germany Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 30 UK Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 31 UK Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 32 UK Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 33 UK Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 34 France Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 35 France Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 36 France Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 37 France Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 38 Italy Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 39 Italy Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 40 Italy Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 41 Italy Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 42 Spain Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 43 Spain Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 44 Spain Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 45 Spain Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 46 Sweden Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 47 Sweden Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 48 Sweden Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 49 Sweden Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 50 Denmark Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 51 Denmark Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 52 Denmark Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 53 Denmark Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 54 Norway Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 55 Norway Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 56 Norway Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 57 Norway Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 58 Asia Pacific Intravenous (IV) Hydration Therapy market, by country, 2021 - 2033 (USD Million)
  • Table 59 Asia Pacific Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 60 Asia Pacific Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 63 China Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 64 China Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 65 China Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 66 China Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 67 Japan Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 68 Japan Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 69 Japan Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 70 Japan Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 71 India Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 72 India Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 73 India Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 74 India Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 75 Australia Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 76 Australia Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 77 Australia Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 78 Australia Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 79 Thailand Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 80 Thailand Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 81 Thailand Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 82 Thailand Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 83 South Korea Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 84 South Korea Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 85 South Korea Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 86 South Korea Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 87 Latin America Intravenous (IV) Hydration Therapy market, by country, 2021 - 2033 (USD Million)
  • Table 88 Latin America Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 89 Latin America Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 90 Latin America Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 91 Latin America Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 92 Brazil Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 93 Brazil Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 94 Brazil Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 95 Brazil Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 96 Argentina Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 97 Argentina Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 98 Argentina Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 99 Argentina Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 100 MEA Intravenous (IV) Hydration Therapy market, by country, 2021 - 2033 (USD Million)
  • Table 101 MEA Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 102 MEA Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 103 MEA Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 104 MEA Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 105 South Africa Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 106 South Africa Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 107 South Africa Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 108 South Africa Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 109 Saudi Arabia Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 110 Saudi Arabia Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 111 Saudi Arabia Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 113 UAE Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 114 UAE Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 115 UAE Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 116 UAE Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 117 Kuwait Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 118 Kuwait Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 119 Kuwait Intravenous (IV) Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 120 Kuwait Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Intravenous (IV) Hydration Therapy market: Market outlook
  • Fig. 5 Intravenous (IV) Hydration Therapy market: Segment outlook
  • Fig. 6 Intravenous (IV) Hydration Therapy market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Intravenous (IV) Hydration Therapy Market Driver Impact
  • Fig. 9 Intravenous (IV) Hydration Therapy market Restraint impact
  • Fig. 10 Intravenous (IV) Hydration Therapy market, Service outlook key takeaways (USD Million)
  • Fig. 11 Intravenous (IV) Hydration Therapy market: Service movement analysis (USD Million)
  • Fig. 12 Immune Boosters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Energy Boosters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Hydration market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Beauty/ Aesthetics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Detoxification market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Longevity/ Antiaging market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Performance/ Athletics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Migraine & Pain Relief market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Stress/Sleep/Mood Support market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Flu/Stomach market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Intravenous (IV) Hydration Therapy market, component outlook: Key takeaways, (USD Million)
  • Fig. 24 Intravenous (IV) Hydration Therapy market: component movement analysis, (USD Million)
  • Fig. 25 Medicated market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Non-Medicated market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Intravenous (IV) Hydration Therapy market, provider type outlook key takeaways (USD Million)
  • Fig. 28 Intravenous (IV) Hydration Therapy market: provider type movement analysis, (USD Million)
  • Fig. 29 Mobile Providers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Physical Providers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Intravenous (IV) Hydration Therapy market, end use outlook key takeaways (USD Million)
  • Fig. 32 Intravenous (IV) Hydration Therapy market: end use movement analysis, (USD Million)
  • Fig. 33 Hospitals & Clinics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Wellness Centers & Spas market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Home Healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 Intravenous (IV) Hydration Therapy market: Regional outlook, 2024 & 2033
  • Fig. 39 North America Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 US Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Canada Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Mexico Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Europe Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 UK Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Germany Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 France Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Italy Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Spain Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Denmark Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Sweden Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Norway Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Asia Pacific Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Japan Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 China Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 India Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 South Korea Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Australia Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Thailand Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Latin America Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Brazil Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 MEA Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 South Africa Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Saudi Arabia Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 UAE Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Kuwait Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)